Announcement on the Progress of the Company's Investigation by the China Securities Regulatory Commission and Risk Warning
The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Shenzhen Changsheng Biotechnology Co., Ltd. (hereinafter referred to as "the Company") received the "Investigation Notice" (Su Zheng Diao Cha Zi [2019035]) from the China Securities Regulatory Commission (hereinafter referred to as "CSRC") on May 10, 2019, due to the failure to disclose the 2018 annual report within the statutory period, leading to the initiation of an investigation.